Impact of body mass index (BMI) on pathological response after neoadjuvant therapy (NAT) in patients with hormone receptor (HR) and HER2 positive early breast cancer (eBC) - single center experience

Results

Title:	Impact of body mass index (BMI) on pathological response after neoadjuvant therapy (NAT) in patients with hormone receptor (HR) and HER2 positive early breast cancer (eBC) - single center experience
Authors:	Djurmez, O; Calamac, M; Dimitrijevic, M; Minic, I; Oblakovic-Babic, J; Serovic, K; Stanic, N; Mihajlovic, S; Gavrilovic, D; Bozovic-Spasojevic, I
Issue Date:	2025
Publication:	BREAST
ISSN:	0960-9776 Breast Search Idenfier
Type:	Conference Paper
Collation:	vol. 80 str. 104105-104105
DOI:	10.1016/j.breast.2025.104105
WoS-ID:	001461202300113
URI:	https://enauka.gov.rs/handle/123456789/978085
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

Altmetric

Dimensions

Unpaywall

Google Scholar^TM